Table 2 Brief summarization of included patients
Characteristics | 25 patients |
|---|---|
Sex (male / female) | 13/12 |
Median age (year) | 55 (7–83) |
Underlying disease | 21 (0.84) |
Pulmonary tuberculosis | 11 (0.44) |
Pulmonary cystic fibrosis | 4 (0.16) |
Bronchiectasis | 3 (0.12) |
Previous diagnosis of S. apiospermum | 1 (0.04) |
Pulmonary arterial hypertension | 1 (0.04) |
Diabetes | 1 (0.04) |
Previous tumor history | 1 (0.04) |
Oral abscess | 1 (0.04) |
No underlying disease | 4 (0.16) |
Clinical manifestations | |
    Cough, Expectoration | 16 (0.64) |
    Hemoptysis | 12 (0.48) |
    Fever | 10 (0.40) |
    Dyspnea | 9 (0.36) |
    Night sweats | 3 (0.12) |
    Blood in sputum | 2 (0.08) |
    Weight loss | 3 (0.12) |
    Loss of appetite | 2 (0.08) |
    Chest pain | 2 (0.08) |
    Fatigue | 2 (0.08) |
    Pneumothorax | 1 (0.04) |
Diagnosis time | |
    Misdiagnosed | 9 (0.36) |
    No misdiagnosis | 16 (0.64) |
Diagnostic methods | |
    BALF culture | 13 (0.52) |
    Sputum culture | 7 (0.28) |
    Blood culture | 1 (0.04) |
    Lung biopsy tissue smear | 1 (0.04) |
    Lung biopsy tissue specimen culture | 2 (0.08) |
    Postoperative tissue culture | 4 (0.16) |
    DNA/RNA sequencing of BALF | 2 (0.08) |
Lesion range | |
    Limited | 12 (0.48) |
    Extensive | 13 (0.52) |
Treatment scheme | |
    Antifungal therapy | 15 (0.60) |
    Surgery treatment | 4 (0.16) |
    Antifungal + Surgery | 6 (0.24) |
Prognosis | |
    Cure | 19 (0.76) |
    Improvement | 2 (0.08) |
    Death | 2 (0.08) |
    No mention | 2 (0.08) |